Company Search:
Advanced Search
Sponsored Links
Curasan AG Company Snapshot
Curasan AG operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Curasan AG with three other pharmaceutical manufacturers in Europe: Byotrol PLC of the United Kingdom (2015 sales of £3.25 million [US$4.03 million] of which 62% was Professional), Nuevolution AB (publ) of Sweden (29.73 million Swedish Kronor [US$3.35 million] ), and Co Don AG (5.09 million Euro [US$5.45 million] of which 100% was Product sales).

Sales Analysis. Curasan AG reported sales of 5.62 million Euro (US$6.02 million) for the year ending December of 2015. This represents a decrease of 6.2% versus 2014, when the company's sales were 5.99 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Curasan AG
  Stock Performance Chart for Curasan AG
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 1.09
(Figures in Euro)
1 Week 1.4%   13 Weeks 1.4%  
4 Weeks 7.4%   52 Weeks 3.3%  
Curasan AG Key Data:
  Ticker: CUR Country: Germany
  Exchanges: DUS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 5,619,000
(Year Ending Jan 2016).
Employees: 35
  Currency: Euro Market Cap: 10,238,106
  Fiscal Yr Ends: December Shares Outstanding: 9,436,042
  Share Type: Common Closely Held Shares: 1,926,765
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.